跳至主要内容
临床试验/NCT02551627
NCT02551627撤回不适用

Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children (7-10yrs; Inclusive) in Bangladesh: a Randomised, Double Blind Controlled Trial

GlaxoSmithKline0 个研究点开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Vaccine response test

研究概览

简要总结

This will be a double blind, two-arm, parallel-group, stratified for gender, randomised, controlled study in participants aged 7-10 years (yrs). The aim of the study is to test the hypothesis that MMN fortified beverage may help improve immunity outcomes as assessed through vaccine response in 7-10 yrs old school participants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
7 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Understanding and willingness to participate in the study as demonstrated by participants' parents and/or Legally acceptable representatives (LARs) voluntary written informed consent, participants' written assent
  • Participants aged between 7-10 yrs, inclusive
  • Good general and mental health
  • Participants with Z-scores of BMI for age of ≥-3 to ≤+1

排除标准

  • Children in Care (CiC)
  • Known or suspected intolerance or hypersensitivity to the study material or any of their stated ingredients or any known food allergies like peanut allergy, gluten allergy or lactose intolerance
  • Participant who has already been administered cholera vaccine in any form prior to this study and any known contra-indication to oral cholera vaccine
  • Participant who consumed any antibiotics during the week prior to the first dose of study vaccination until the end of the study
  • Severe anemia (Hb < 8 g/dL), recent history (2 months) of serious infections, injuries and/or surgeries
  • Participant consuming nutritional supplement and/or health food drinks on regular basis (≥ 3 times a week) in last 3 months
  • Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder
  • Participants likely to move out of geographical range of the study within study duration
  • Child of an employee of the sponsor or the study site or members of their immediate family, sibling of participant already enrolled in the study
  • Previous participation in this study, in another clinical study or receipt of an investigational drug within 30 days of screening visit; participation in any nutritional study or didactic nutritional education in last 6 months of the screening visit

结局指标

主要结局

Vaccine response test

时间窗: 18 weeks

Proportion of participants demonstrating vaccine reponse, receiving either test product or control will be determined and compared. Vaccine response will be defined as greater than or equal to 4 fold increase from pre-vaccine visit in vibriocidal antibody response 7 days post second vaccine dose.

次要结局

  • Change from baseline in nutrional biochemistry(18 weeks)
  • Absolute vibriocidal antibody titer(18 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验